Sacrificing one visual hemifield during pediatric epilepsy surgery: Effects on visual search.


Journal

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society
ISSN: 1532-2130
Titre abrégé: Eur J Paediatr Neurol
Pays: England
ID NLM: 9715169

Informations de publication

Date de publication:
Nov 2020
Historique:
received: 04 05 2020
revised: 23 08 2020
accepted: 14 09 2020
pubmed: 30 9 2020
medline: 16 3 2021
entrez: 29 9 2020
Statut: ppublish

Résumé

To investigate early and late effects of planned surgically acquired homonymous hemianopias on visual search in children and adolescents. This prospective study included five patients (5y 5 m-18y 0 m; 2 girls) with pharmaco-refractory epilepsies in whom one visual hemifield was sacrificed as part of the surgical strategy, and, as controls, seven patients (5y 11 m-18y 0 m; 6 girls) undergoing epilepsy surgeries not affecting the visual fields. Visual search was studied using the "Table Test", which is an everyday life-like visual search test. General processing speed was studied using a standard IQ subtest. All five patients with newly acquired homonymous hemianopias showed a relative disadvantage of visual search times for objects in their newly blind hemifields immediately after the surgery. Six months later, this relative disadvantage had recovered completely in all patients. Nevertheless, compared with the preoperative situation, overall search times were still prolonged in the hemianopic patients, but this effect could be mitigated or even overcompensated by improvements in processing speed. Children with homonymous hemianopias inflicted by epilepsy surgery develop effective compensation strategies to minimize the relative disadvantage of visual search in their blind hemifields. For changes in overall visual search times between the preoperative and the six-month follow-up examination, we could demonstrate overlapping effects of (a) deterioration by hemianopia and (b) amelioration by improved processing speed as part of the cognitive improvements achieved by amelioration of the epilepsy.

Identifiants

pubmed: 32988735
pii: S1090-3798(20)30187-2
doi: 10.1016/j.ejpn.2020.09.003
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

103-107

Informations de copyright

Copyright © 2020 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.

Auteurs

Lisa Neumayr (L)

Center for Pediatric Neurology, Neurorehabilitation and Epileptology, Schön Klinik, Vogtareuth, Vogtareuth, Germany; Department of Pediatric Neurology and Developmental Medicine, University Children's Hospital, Tübingen, Germany. Electronic address: LNeumayr@schoen-klinik.de.

Alisa Gschaidmeier (A)

Center for Pediatric Neurology, Neurorehabilitation and Epileptology, Schön Klinik, Vogtareuth, Vogtareuth, Germany; Department of Pediatric Neurology and Developmental Medicine, University Children's Hospital, Tübingen, Germany.

Susanne Trauzettel-Klosinski (S)

Vision Rehabilitation Research Unit, Center for Ophthalmology, University of Tübingen, Tübingen, Germany.

Tom Pieper (T)

Center for Pediatric Neurology, Neurorehabilitation and Epileptology, Schön Klinik, Vogtareuth, Vogtareuth, Germany.

Manfred Kudernatsch (M)

Center for Pediatric Neurology, Neurorehabilitation and Epileptology, Schön Klinik, Vogtareuth, Vogtareuth, Germany; Research Institute "Rehabilitation, Transition, Palliation" PMU Salzburg, Salzburg, Austria.

Wiebke Hofer (W)

Center for Pediatric Neurology, Neurorehabilitation and Epileptology, Schön Klinik, Vogtareuth, Vogtareuth, Germany.

Christina Bajer (C)

Center for Pediatric Neurology, Neurorehabilitation and Epileptology, Schön Klinik, Vogtareuth, Vogtareuth, Germany.

Martin Staudt (M)

Center for Pediatric Neurology, Neurorehabilitation and Epileptology, Schön Klinik, Vogtareuth, Vogtareuth, Germany; Department of Pediatric Neurology and Developmental Medicine, University Children's Hospital, Tübingen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH